SLAMF7 and Miyoshi myopathy: Most recently, SLAMF7 was found highly expressed on immunosuppressive CD8+CD28-CD57+ Tregs in MM patients and these cells could be eliminated using anti-SLAMF7 MoAb elotuzumab [25].